ConductScience.org, home

Paper · 5317954

The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.

Oates JA and 4 others. N Engl J Med, 1965. Cited by 63 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. Papers, record 5317954. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5317954

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
PubMed
Journal
N Engl J Med
PubMed
Year
1965
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
63
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Oates JAJ A
2Seligmann AWA W
3Clark MAM A
4Rousseau PP
5Lee RER E

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GuanethidineMajor topic
HypertensionMajor topic
MethyldopaMajor topic
PargylineMajor topic
Clinical Trials as Topic
Humans
Hypotension, Orthostatic

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
30,255,284A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.J Neural Transm (Vienna)2018https://conductscience.org/library/papers/30255284PubMed
20,919,347Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.Proc R Soc Med1977https://conductscience.org/library/papers/20919347PubMed
20,791,420Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison.Br Med J1968https://conductscience.org/library/papers/20791420PubMed
20,791,413Drugs in control of hypertension.Br Med J1968https://conductscience.org/library/papers/20791413PubMed
19,821,316Methyldopa for primary hypertension.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19821316PubMed
18,730,059Recent concepts in the clinical pharmacology of anithypertensive drugs.Calif Med1967https://conductscience.org/library/papers/18730059PubMed
6,025,595Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).Br Med J1967https://conductscience.org/library/papers/6025595PubMed
5,761,914Treatment of hypertension with propranolol.Br Med J1969https://conductscience.org/library/papers/5761914PubMed
5,381,984[Fluorescence histochemical studies on the effect of alpha methyldopa on rat small intestine].Klin Wochenschr1969https://conductscience.org/library/papers/5381984PubMed
5,127,116Hypertension and depression: interrelated problems in therapy.J R Coll Physicians Lond1971https://conductscience.org/library/papers/5127116PubMed

1 to 10 of 17

See all 17 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5317954

GET https://conductscience.org/api/papers/v1/5317954/authors